Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus
(WorldNews Switzerland)

Basel, 22 July 2019 Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus Access to innovative diagnostic solutions will contribute to the World Health Organization`s infectious disease elimination goals Improving access to reliable diagnostics for disease management in countries with the highest burden Early detection of infectious diseases with diagnostics helps clinicians save lives Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and...